» Articles » PMID: 35059468

Circular RNA CircFGFR1 Functions As an Oncogene in Glioblastoma Cells Through Sponging to Hsa-miR-224-5p

Overview
Journal J Immunol Res
Publisher Wiley
Date 2022 Jan 21
PMID 35059468
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, increased studies have shown the important regulatory role of circular RNA (circRNA) in cancer progression and development, including glioblastoma (GBM). However, the function of circRNAs in glioblastoma is still largely unclear. Here, we state that circFGFR1 is elevated in glioma cells, resulting in aggravated glioma aggravated malignancy. The upregulation of circFGFR1 also promotes glioma growth in mouse xenograft models. Furthermore, CXCR4 level in glioma cells is positively correlated with circFGFR1 level, and higher CXCR4 expression is found in circFGFR1 overexpression groups. The effect of circFGFR1 on glioma malignancy is abolished in CXCR4 knockout cells. Then, RIP, RNA pull-down, and luciferase reporter assay results showed that hsa-miR-224-5p directly binds to circFGFR1 and CXCR4 mRNA. The CXCR4 3'-untranslated region (UTR) activated luciferase activity was reduced with hsa-miR-224-5p transfection, while it is reversed when cotransfected with circFGFR1, indicating that circFGFR1 acts as a hsa-miR-244-5p sponge to increase CXCR4 expression. The hsa-miR-224-5p expression is negatively corrected with the glioma malignancy through inhibiting CXCR4 level. Besides, the circFGFR1-induced regulation in glioma malignancy is also abrogated in hsa-miR-224-5p knockout cells. Taken together, our findings suggest that circFGFR1 plays a critical role in the tumorigenic behaviors in glioma cells by upregulating CXCR4 expression via sponging to hsa-miR-224-5p. These findings provide a new perspective on circRNAs during GBM development.

Citing Articles

The Role of the Dysregulation of circRNAs Expression in Glioblastoma Multiforme.

Wang Y, Yu Y, Yu J, Wang C, Wang Y, Fu R J Mol Neurosci. 2025; 75(1):9.

PMID: 39841303 DOI: 10.1007/s12031-024-02285-5.


Elucidating the impact of parthanatos-related microRNAs on the tumoral immune microenvironment and clinical outcome in low-grade gliomas.

Zhu P, Wu H, Zheng B, Wang H, Zou Y Discov Oncol. 2024; 15(1):153.

PMID: 38730061 PMC: 11087408. DOI: 10.1007/s12672-024-01025-w.


Downregulated M6A modification and expression of circRNA_103239 promoted the progression of glioma by regulating the miR-182-5p/MTSS1 signalling pathway.

Zhang S, Zhang P, Wu A, Xu Z, Huang S, Liu X J Cancer. 2023; 14(18):3508-3520.

PMID: 38021156 PMC: 10647192. DOI: 10.7150/jca.85320.


The Glioblastoma CircularRNAome.

Tirpe A, Streianu C, Tirpe S, Kocijancic A, Pirlog R, Pirlog B Int J Mol Sci. 2023; 24(19).

PMID: 37833993 PMC: 10572686. DOI: 10.3390/ijms241914545.


Underlying mechanisms and clinical potential of circRNAs in glioblastoma.

Zhang L, Zhang Y, Gao H, Li X, Li P Oncol Res. 2023; 31(4):449-462.

PMID: 37415736 PMC: 10319586. DOI: 10.32604/or.2023.029062.


References
1.
Ostrom Q, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. Neuro Oncol. 2017; 18(suppl_5):v1-v75. PMC: 8483569. DOI: 10.1093/neuonc/now207. View

2.
Yu M, Xue Y, Zheng J, Liu X, Yu H, Liu L . Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol Cancer. 2017; 16(1):110. PMC: 5485714. DOI: 10.1186/s12943-017-0677-9. View

3.
Qiu B, Zhang P, Xiong D, Xu J, Long X, Zhu S . CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling. J Cell Physiol. 2018; 234(7):11256-11264. DOI: 10.1002/jcp.27783. View

4.
Broggi G, Salvatorelli L, Barbagallo D, Certo F, Altieri R, Tirro E . Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas. Cancers (Basel). 2021; 13(9). PMC: 8123436. DOI: 10.3390/cancers13092086. View

5.
Peng X, Guo C, Wu Y, Ying M, Chang R, Song L . miR‑224‑5p regulates the proliferation, migration and invasion of pancreatic mucinous cystadenocarcinoma by targeting . Mol Med Rep. 2021; 23(5). PMC: 7974333. DOI: 10.3892/mmr.2021.11985. View